Photoadaptation to ultraviolet (UV) radiation in vivo: photoproducts in epidermal cells following UVB therapy for psoriasis.

Type:Uv phototherapy   Time:2017-10-13 16:37:47
Photoadaptation to ultraviolet (UV) radiation in vivo: photoproducts in epidermal cells following UVB therapy for 
psoriasis.
BACKGROUND:
Ultraviolet (UV) radiation is mutagenic and induces specific DNA lesions in human skin that are often found at 
dipyrimidine sites. These photoproducts are likely to be biologically relevant regarding skin carcinogenesis, as p53 
mutations in skin tumours are most often found at these UV radiation-specific sites within DNA. Psoriasis patients 
receiving long-term phototherapy are at an increased risk of non-melanoma skin cancers.
OBJECTIVES:
The aim of this study was to quantify DNA photoproducts in human epidermis in vivo following consecutive doses of UVB 
and to investigate variations in DNA damage according to skin type, UVB dose and age.
METHODS:
Eleven psoriasis patients receiving UVB phototherapy three times a week were recruited and underwent skin biopsies on 
a non-sun-exposed site before starting phototherapy and after three, nine and 18 UVB exposures. A biopsy was also 
taken at least 4 weeks after stopping phototherapy. DNA was extracted from separated epidermis and three types of 
photoproducts were quantified using a novel 32P high-performance liquid chromatographic technique.
RESULTS:
The mean level of cyclobutane dipyrimidine dimers (CPDs) after three doses of UVB (dose range 0.03-0.15 J cm-2) was 
3.2 (range 0.8-8.9) photoproducts per 106 normal nucleotides for TT=T dimers and 4.5 (range 0-14) per 106 normal 
nucleotides for TT=C dimers. The mean levels of TT-C 6-4 photoproducts after three doses of UVB were very low (0.2, 
range 0-1.8). Overall, the levels of TT=T and TT=C reached a plateau at three exposures and were found to decrease for 
subsequent exposures despite increasing UVB doses. Skin type was negatively associated with mean levels of CPDs. 
However, significant differences in levels of photoproducts were seen between individuals, even after adjusting for 
skin type. No association was found between challenge dose of UVB and photoproduct yield in this study.
CONCLUSIONS:
This study showed a great individual variation in the accumulation of DNA photoproducts following exposure to 
repetitive doses of UVB. Photoadaptive responses of human skin involving DNA repair, tanning and epidermal thickening 
are likely to explain the overall lack of increase in DNA lesions throughout phototherapy. This in vivo study confirms 
that psoriasis patients produce a significant amount of DNA photolesions at suberythemal doses of UVB. Further work is 
needed to investigate which host factors are most likely to predict susceptibility to UV radiation-induced DNA damage
www.kerneluvb.com----The leader manufacturer of UVB Phototherapy.